Cigna Group, US1255231003

Cigna Group stock: Cigna Group schedules November 5 results for Cigna Group stock

Published on 10/22/2026 at 17:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Second-quarter revenue hit USD 71.67 billion, up 6.70 percent. Cigna Group stock costs EUR 277.60 on October 22, 2026, 2.21 percent above Xetra close.

Reporting date November 5, 2026

  • Cigna Group's next earnings report is scheduled for November 5, 2026.
  • Second-quarter revenue reached USD 71.67 billion, up 6.70 percent year over year.
  • Cigna Group stock costs EUR 277.60 at Lang & Schwarz on October 22, 2026 at 5:04 p.m. CEST, 2.21 percent above the Xetra close of October 21, 2026.
  • The stock's P/E is 12.60 and its market capitalization is USD 73.3 billion as of October 22, 2026.
Cigna Group Bauhaus-Poster geometrisch mit HEALTH INSURANCE Sektortext, ISIN US1255231003, Primärfarben im Konstruktivismus-Stil, Illustration mit AI erstellt.

Cigna Group is scheduled to report its next earnings on November 5, 2026, according to Mindtrajour. The stock was trading at EUR 277.60 at Lang & Schwarz on October 22, 2026 at 5:04 p.m. CEST, up 2.21 percent versus the Xetra close of October 21, 2026 at EUR 271.60.

Revenue growth sets the backdrop

The company's latest reported quarter showed total revenue of USD 71.67 billion, an increase of 6.70 percent from the year-earlier period. Yahoo Finance reported that adjusted earnings per share reached USD 7.78 in the second quarter of 2026, while the company raised its full-year adjusted earnings-per-share outlook to at least USD 30.45.

The second-quarter figures give the November report a clear comparison point. The company recorded USD 1.875 billion in consolidated net income and USD 2.676 billion in operating profit for the quarter ended June 30, 2026. Its operating margin was 3.70 percent, reflecting the high revenue volume that runs through its health services and pharmacy businesses.

Stock position and valuation

Cigna Group's market capitalization was USD 73.3 billion as of October 22, 2026, while its P/E was 12.60. The stock's current euro quotation is above the Xetra close by EUR 6.00, which translates into the 2.21 percent daily increase shown above.

The primary listing is on the NYSE under ticker CI. Markets Insider reported on October 2, 2026 that Piper Sandler raised its Cigna price target from USD 346.00 to USD 370.00 and retained an Overweight rating. That target update predates the November reporting date and provides a separate valuation reference in the company's home currency.

What comes next for earnings

The November 5 report is expected before the market opens, giving investors a defined near-term date for testing the USD 30.45 adjusted earnings-per-share outlook. The second-quarter call also said Specialty and Care Services adjusted earnings grew 22.00 percent year over year to USD 1.10 billion, while Cigna Healthcare revenue rose 10.00 percent to USD 11.80 billion.

Cigna's operating picture therefore combines high nominal revenue with comparatively narrow operating margins. The next report will show whether the specialty business continues to offset pressure in pharmacy benefit services.

Stock quote and investor view

The October 22 quotation places Cigna Group stock at EUR 277.60 at Lang & Schwarz at 5:04 p.m. CEST, 2.21 percent above the Xetra close of October 21, 2026 at EUR 271.60. The November reporting date and the USD 30.45 full-year adjusted earnings-per-share outlook are the two clearest dates and figures for the next review.

The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.

Cigna Group stock at a glance

  • Company: Cigna Group
  • ISIN: US1255231003
  • Ticker: CI
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 22, 2026, 5:04 p.m. CEST): EUR 277.60
  • Change versus Xetra close: plus 2.21 percent
  • Xetra close (October 21, 2026): EUR 271.60
  • Market capitalization: USD 73.3 billion (as of October 22, 2026)
  • Sector / Industry: Healthcare / Medical - Healthcare Plans

Market context: Market report S&P 500.

More news and analyses on Cigna Group stock

Disclaimer...
en | US1255231003 | CIGNA GROUP | boerse | 70394449 | bgmi